RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of REPCF
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

FAQ

What is the symbol for Replicel Life Science Ord Stock and on which exchange is it traded?
The symbol for Replicel Life Science Ord is REPCF and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell Replicel Life Science Ord Stock?
Replicel Life Science Ord holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Replicel Life Science Ord Stock?
Replicel Life Science Ord Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Replicel Life Science Ord Stock.

What's the current price of Replicel Life Science Ord Stock?
As of the end of day on the 2024-03-27, the price of an Replicel Life Science Ord (REPCF) share was $0.0428.

What is the 52-week high and low for Replicel Life Science Ord Stock?
The 52-week high for Replicel Life Science Ord Stock is $0.186 and the 52-week low is $0.0257.

What is the market capitalization of Replicel Life Science Ord Stock?
As of the 2024-03-27, the market capitalization of Replicel Life Science Ord is 2.784M.

When is the next earnings date for Replicel Life Science Ord?
The upcoming earnings date for Replicel Life Science Ord is May 01, 2024.
Click to get the best stock tips daily for free!

About Replicel Life Science Ord

Replicel Life Science Ord RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01 for the treatment of chronic tendinosis; RCS-01 to treat aging and sun damaged skin;... REPCF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT